OncoFirm™ CEA
Rapid Lateral Flow Immunoassay for Carcinoembryonic Antigen (CEA) Investigational device in the United States. OncoFirm™ CEA has not been cleared or approved by the U.S. Food and Drug Administration and…
-
-
OncoFirm™ AFP
OncoFirm™ AFP Rapid Test for Alpha-Fetoprotein (AFP) – Liver Cancer (Hepatocellular Carcinoma) Screening Overview:OncoFirm™ AFP is a rapid, point-of-care diagnostic test designed for the early detection and monitoring of hepatocellular…
-
OncoFirm™ PSA
Rapid Lateral Flow Immunoassay for Total Prostate-Specific Antigen (PSA) Investigational device in the United States. OncoFirm™ PSA has not been cleared or approved by the U.S. Food and Drug Administration…
-
OncoFirm™MultiDx
Investigational Multiplex Lateral Flow Assay for Cancer-Associated Biomarkers Investigational device. OncoFirm™ MultiDx is in development and has not been cleared or approved by the U.S. Food and Drug Administration or…
-
OncoFirm™-L
Investigational Rapid Lateral Flow Assay for Thomsen–Friedenreich (TF) Glycoantigen Investigational device. OncoFirm™-L is in development and has not been cleared or approved by the U.S. Food and Drug Administration [or…
-
OncoFirm™ -B
OncoFirm™ -B Rapid Test for Breast and Ovarian Cancer Detection Overview:OncoFirm™ -B is an advanced rapid diagnostic test developed by OncoFirm Diagnostics for the early detection of breast and ovarian…
-
OncoFirm™ -R
OncoFirm™ -R: Rapid test for colorectal and pancreatic cancers. OncoFirm™ -R Rapid Test for Colorectal and Pancreatic Cancer Detection Overview:OncoFirm™ -R is a high-performance lateral flow rapid test developed by…
-
Applications | Our Newsroom - Posts, Stories and Strategies... | Our Research Areas - Human Cancer Antigens | Technology
Thomsen-Friedenreich (TF) antigen
Thomsen–Friedenreich (TF) Antigen: A Key Marker in Cancer Biology The Thomsen–Friedenreich (TF) antigen, also known as CD176, is a simple two‑sugar structure (galactose + N‑acetylgalactosamine) normally hidden on healthy cells….
-
KRAS Mutations
KRAS mutations are among the most common oncogenic drivers in human cancers, notably in pancreatic, colorectal, and lung cancers. The KRAS gene encodes a protein that functions as a molecular…
-
TP53 (Tumor Protein p53)
TP53 (Tumor Protein p53)
